DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies

VEGF-targeted therapy increases both the progression-free (PFS) and overall survival (OS) of patients with metastasized renal cell cancer (mRCC). Identification of molecular phenotypes of RCC could improve risk-stratification and the prediction of the clinical disease course. We investigated whether...

詳細記述

保存先:
書誌詳細
主要な著者: Peters, Inga, Dubrowinskaja, Natalia, Abbas, Mahmoud, Seidel, Christoph, Kogosov, Michael, Scherer, Ralph, Gebauer, Kai, Merseburger, Axel S., Kuczyk, Markus A., Grünwald, Viktor, Serth, Jürgen
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2014
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3954691/
https://ncbi.nlm.nih.gov/pubmed/24633192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0091440
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料